| Research Article |
Open Access |
|
| A Comprehensive Curated Reaction Map of Leptin Signaling Pathway |
| Vishalakshi Nanjappa1, Rajesh Raju1, Babylakshmi Muthusamy1,2, Jyoti Sharma1,3, Joji Kurian Thomas1, Pachakkil A. Haridas Nidhina4, H.
C. Harsha1, Akhilesh Pandey5,6,7,8, Gopalakrishnapillai Anilkumar4 and T. S. Keshava Prasad1,2,3* |
| 1Institute of Bioinformatics, International Tech Park, Bangalore-560 066, India |
| 2Centre for Bioinformatics, School of Life Sciences, Pondicherry University, Puducherry-605 014, India |
| 3Manipal University, Madhav Nagar, Manipal-576 104, India |
| 4School of Biotechnology, Amrita Vishwa Vidyapeetham, Kollam-690 525, India |
| 5McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA |
| 6Departments of Biological Chemistry, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA |
| 7Pathology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA |
| 8Oncology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA |
| *Corresponding author: |
Dr. T. S. Keshava Prasad Ph.D.
Institute of Bioinformatics,
International Tech Park
Whitefield, Bangalore-560066
Tel: 91-80-28416140
Fax:
91-80-28416132 E-mail: keshav@ibioinformatics.org |
|
| |
| Received April 13, 2011; Accepted September 13, 2011; Published September
21, 2011 |
| |
| Citation: Nanjappa V, Raju R, Muthusamy B, Sharma J, Thomas JK, et al. (2011) A
Comprehensive Curated Reaction Map of Leptin Signaling Pathway. J Proteomics
Bioinform 4: 184-189. doi:10.4172/jpb.1000188 |
| |
| Copyright: © 2011 Nanjappa V, et al. This is an open-access article distributed
under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the
original author and source are credited. |
| |
| Abstract |
| |
| Leptin, a peptide hormone, regulates endocrine function and maintains body weight homeostasis by regulating
food intake and energy expenditure via hypothalamus-mediated effects. Impairment in leptin signaling induces
obesity, a major health problem worldwide. Leptin signaling regulates other physiological processes such as
angiogenesis, hematopoiesis and also has effects on the reproductive, cardiovascular and immune systems. Despite
its biomedical importance, a comprehensive catalog of the signaling events activated by leptin is not available as a
public resource. Therefore, we initiated cataloging of the molecular reactions in this pathway to develop a detailed
reaction map of leptin signaling. For the benefit of scientific community, we provided the leptin signaling pathway
through NetPath (http://www.netpath.org), a freely accessible pathway resource previously developed by our group.
We anticipate that leptin/leptin receptor signaling map and the data comprising these signaling events will enable
future biomedical investigations. |
| |
| Keywords |
| |
| Cytokine; Leptin resistance; Adipocyte; Energy
homeostasis; PathVisio; NetSlim |
| |
| Introduction |
| |
| Leptin is a peptide hormone primarily synthesized and secreted
by adipocytes of white fat [1]. It is also expressed in secondary sites
including stomach, placenta and skeletal muscle [1,2]. Leptin activates
various pathways through leptin receptor encoded by the LEPR gene
[3]. Leptin receptor, also called OB receptor (OBR), is a member of
gp130 family of cytokine receptors [4]. LEPR is expressed in many
tissues including the hypothalamus of the brain, adipose tissue, heart,
placenta, lung and liver [1,4-6]. Six isoforms of LEPR-LEPRa, LEPRb,
LEPRc, LEPRd, LEPRe and LEPRf have been reported [7,8]. LEPRb
is the longest leptin receptor and is described in most of the signal
transduction studies [9,10]. LEPRe is the secretory isoform and is
known to control circulating leptin levels [11]. Role of LEPRa, LEPRc,
LEPRd and LEPRf in leptin signaling is not clear [8]. Leptin associates
with its receptor in 1:1 stoichiometry and forms a tetrameric receptor/
ligand complex [3,12]. LEPRb forms homodimer and can also form
heterodimer with LEPRa and LEPRc [13,14]. Homodimer of LEPRb is
found to be essential to transduce leptin dependent signaling [14,15].
Besides, it is also reported that heterodimer of LEPRa and LEPRb is
reported to lack signaling capacity [14]. LEPRb does not have intrinsic
kinase activity. Therefore, it mediates multiple signaling pathways
through cytoplasmic kinases including Janus Kinase 2 (JAK2) [16]. |
| |
| Leptin was detected in various regions of the brain including
hypothalamus, cerebral cortex and cerebellum [17]. It was found to be
transported to these areas of the brain across the blood brain barrier
[18]. Impairment in this transport of leptin across blood brain barrier
is considered to be one of the factors that contribute to leptin resistance
and thus obesity [19]. Leptin plays a major role in the regulation of
energy homeostasis and neuroendocrine function [20,21]. High serum
leptin levels are mainly associated with obesity. Leptin concentration is
higher in obese individuals. Obesity is rather related to leptin tolerance
or resistance but not due to leptin deficiency [22,23]. |
| |
| Leptin is also known to regulate reproduction, bone homeostasis
and immune signaling [24,25]. In humans, females have twice the
amount of circulating leptin than that of males [26]. A certain level
of circulating leptin has implication in the maintenance of menstrual
cycles and normal reproductive function [27]. Serum leptin levels
determine the onset of puberty and also vary during pregnancy [28,29].
Excess levels of leptin, defective leptin signaling and leptin resistance
are associated with abnormal reproductive function [30]. Previously,
studies have shown that mice without a functional LEPR were obese
and infertile [31,32]. Impaired leptin signaling in these obese mice had
poor outcome in embryo implantation [33]. Leptin also stimulates
bone growth and acts as a suppressor of bone resorption [34,35].
Being a proinflammatory cytokine, leptin also plays an important role
both in innate and adaptive immunity [36]. Elevated levels of leptin
in serum are associated with several autoimmune diseases including
encephalomyelitis and rheumatoid arthritis [37,38] and in several
chronic inflammatory conditions such as nonalcoholic hepatitis and
Behcet’s disease [39,40]. Further, involvement of leptin in angiogenesis
and proliferation of hematopoietic cells has been reported [41-43].
Ishikawa and coworkers have shown that leptin and its receptor are
overexpressed in gastric carcinoma [44]. Leptin stimulation has been
shown to induce progression of estrogen dependent breast cancer
cells and to promote cell proliferation of human acute myelogenous
leukemia cells [45]. |
| |
| Leptin has been implicated in various physiological functions. From
a biomedical point of view, perhaps it is one of the most important
proteins. However, the signaling pathway reactions triggered by LEPLEPR
interaction have not been cataloged in public signaling pathway
resources. Therefore, we sought to create a comprehensive map of the
leptin signaling pathway, which would serve as a reference for leptin
signaling. Our approach to develop leptin pathway map include manual
annotation of individual biochemical reactions induced by leptin.
We have classified these molecular reactions into protein-protein
interactions (PPIs), enzyme-substrate reactions, activation/inhibition
and protein translocation events. In addition, we have also cataloged
genes, which are differentially regulated by leptin signaling. Besides,
transcriptional regulators of these genes were also documented. |
| |
| Methodology |
| |
| PubMed and Information Hyperlinked over Proteins (iHOP) were
searched for articles, which described leptin signaling. We screened
these articles for |
| |
| i) protein-protein interactions; |
| |
| ii) post-translational
modifications; |
| |
| iii) altered localization of proteins; |
| |
| iv) activation/
inhibition of proteins and |
| |
| v) transcriptional regulation of genes and
their regulators; induced by stimulation of leptin receptor with leptin. |
| |
| We have documented these individual information curated from every
full text of articles in PathBuilder, an in-house curation tool, previously
developed by our group [46]. The criteria for such curation included: |
| |
| i)
each reaction must have been observed under the stimulation of leptin
receptor by leptin and should not be under the influence of multiple
ligand-receptor stimulations; |
| |
| ii) the proteins in a reaction must be
mammalian proteins; |
| |
| iii) reactions must have been carried out in
mammalian cell lines and |
| |
| iv) gene expression data was captured only
from normal human cells. |
| |
| Protein-protein interactions (PPIs) |
| |
| PPIs were curated as either binary or complex interactions. Binary
reactions represent homomeric or heteromeric interaction between two
molecules. Complex reactions constitute protein complexes of three or
more proteins where topology of association between components is
not reported. For every PPI, we have documented |
| |
| i) the species of the
interacting proteins; |
| |
| ii) cellular location; |
| |
| iii) species of cell line in which
the experiment was performed; |
| |
| iv) PubMed identifier (hyperlinked to
its corresponding abstract) from which the reaction was captured; and |
| |
| v) a brief comment on PTM dependence, domains or motifs involved
and the names of cell lines in which the reactions were carried out. |
| |
| Enzyme-substrate reactions |
| |
| Post-translational modifications (PTMs) can bring about changes
in the physicochemical properties of a given protein and thereby can
recruit the substrate protein to different subcellular localization [47].
Besides, PTMs can also activate or inhibit the activity of proteins.
For example, phosphorylation and dephosphorylation reactions have
been shown to result in activation and/or inactivation of particular
proteins [48,16,49]. Therefore, we included a comprehensive search
for PTMs including phosphorylation, dephosphorylation, acetylation,
deacetylation and proteolytic cleavage, among others, pertaining to the
leptin signaling pathway. However, we could capture phosphorylation
and dephosphorylation events and not any other types of PTMs. We
categorized these PTM events as direct or induced. Direct PTMs were
those reactions for which the enzyme responsible for the reaction
was known. The upstream enzyme was also documented as a protein
interactor of the substrate. However, where such enzyme was not yet
been identified, the reactions were designated as ‘induced PTMs’. For most PTMs, we have also annotated the site and residue information,
which were further mapped to protein sequences provided in RefSeq
database. In summary, for each enzyme-substrate reaction, we have
captured the following information |
| |
| i) the type of PTM; |
| |
| ii) the site and
residue of modification; |
| |
| iii) the cellular location; |
| |
| iv) the species of the
enzyme and the substrate involved in the reaction; |
| |
| v) the species of
cell line; |
| |
| vi) activation or inhibition status of the substrate in response
to PTMs as reported by specific assays and |
| |
| vii) PubMed identifier of
the article describing the reaction. |
| |
| In addition, a description on the
enzyme, substrate, site and residue of modification, host cell line in
which the reaction was proved was provided for each enzyme-substrate
reaction in ‘Comments’. |
| |
| Activation/Inhibition reactions |
| |
| Leptin signaling was reported to activate or inhibit certain proteins
as evaluated by specific assays. We document activation and inhibition
of such molecules only if these molecules were not reported to be
components of any PPI or PTMs in leptin pathway. In other words,
proteins curated in “Activation/Inhibition” section will be a unique set
of molecules influenced by this signaling pathway. For every activation/
inhibition event, we have captured |
| |
| i) the species of the protein activated
or inhibited; |
| |
| ii) the subcellular localization in which the reaction was
reported; |
| |
| iii) species of cell line in which the experiment was carried out; |
| |
| iv) PubMed identifier; |
| |
| v) cell line in which the reaction was reported
and |
| |
| vi) a brief description of the protein being activated/inhibited. |
| |
| Protein translocation |
| |
| We have documented protein translocation events that were
triggered by leptin signaling. These events can be dependent on PTMs
or physical interactions. In addition to protein’s altered localization,
we have also documented |
| |
| i) the species of the protein being studied; |
| |
| ii)
species of cell line in which the experiment was carried out; |
| |
| iii) the PTM
dependence on translocation and |
| |
| iv) research article hyperlinked to its
abstract in PubMed. |
| |
| A brief description is provided in the ‘Comments’
section comprising the details of primary and altered localization of the
protein, the PTM dependence and the cell lines in which the reaction
was studied. We used controlled vocabularies as defined by Gene
Ontology (GO) for denoting subcellular localization [50]. |
| |
| Gene regulation |
| |
| We have annotated genes that are transcriptionally regulated
by leptin signaling in normal human cells. This includes the genes
whose differential regulation was associated with leptin pathway as
investigated by DNA microarrays, Northern blotting, serial analysis
of gene expression and quantitative PCR. The cell type in which these
genes were identified to be regulated was also documented. In addition,
we also cataloged transcriptional regulators of up- or down-regulated
genes which were detected through various promoter assays pertaining
to leptin signaling. |
| |
| Results and Discussion |
| |
| Our manual curation effort to capture leptin pathway reactions
resulted in cataloging 108 molecules from 130 screened articles. The 108
molecules contributed to 54 direct and 8 complex PPIs, 20 direct and
77 induced catalytic events, 10 activation and 11 translocation events.
We have also cataloged 31 and 79 genes, which were transcriptionally
up or down-regulated, respectively. In addition, we have also curated
transcriptional regulators for ten of these differentially regulated genes.
Each reaction curated in leptin pathway underwent a series of internal
review and also a review by a Pathway Authority (G.A. who is a co author). We would like to adopt this model for curation of pathways in
the future where we involve experts on individual pathways as Pathway
Authorities and include them as co-authors on descriptions of the
corresponding pathways. This will also help us in keeping the pathways
updated. |
| |
| Signaling modules in leptin pathway |
| |
| The signaling modules are well-known sub-pathways without
specific or precise boundaries in interaction networks but are commonly
identified by a name such as mitogen-activated protein kinase (MAPK)
or JUN N-terminal kinase (JNK) pathway. They provide the framework
for the identification and representation of a group of molecules which
are accepted to have specific lineage and function within interaction
networks. Our curation effort of leptin pathway has captured various
signaling modules reported to be induced by leptin receptor activation
in various research articles pertaining to leptin signaling such as JAK/
STAT, RAS/RAF/MAPK, IRS1/PI-3K, PLC-gamma and AMPK/ACC
modules. |
| |
| JAK/STAT signaling module |
| |
| The stimulation of LEPR with leptin induces autophosphorylation
and activation of JAK2 [51]. Activated JAK2 mediates phosphorylation
of LEPR at Tyr-986, Tyr-1078 and Tyr-1141 residues (accession #
NP_002294.2) and thus provides binding for downstream signaling
molecules such as signal transducer and activator of transcription
(STAT) proteins [52,53]. Binding of STATs to the phosphorylated
residues of LEPR leads to the tyrosine phosphorylation of STATs by
JAK2 [54]. Activated STATs dimerize, disassociate from the receptor
and translocate into the nucleus [55]. In the nucleus, they bind to their
specific target nucleotide sequences resulting in the transcription of
genes such as suppressor of cytokine signaling 3 (SOCS3) and TIMP
metallopeptidase inhibitor 1 (TIMP1) [56,57]. SOCS3 induced by
STATs associates with Tyr-986 of LEPR and represses leptin-mediated
signals. Thus, SOCS3 mediates feedback inhibition of LEP/LEPR
pathway [47]. Suppressor of cytokine signaling 7 (SOCS7), another
member of the SOCS family, attenuates LEPR signaling by interacting
with phosphorylated STATs to prevent their nuclear translocation
[58]. Another negative regulator of leptin signaling is protein tyrosine
phosphatase, non-receptor type 1 (PTPN1). Cytosolic PTPN1
dephosphorylates JAK2 and STAT3 thereby negatively regulates leptin
signaling [59]. |
| |
| RAS/RAF/MAPK signaling module |
| |
| Mitogen-activated protein kinase 1/3 (MAPK1/3) pathway is
another signaling module regulated by leptin signaling. Protein tyrosine
phosphatase, non-receptor type 11 (PTPN11) was initially suggested as
a negative regulator of leptin signaling [48] but later it was revealed
that PTPN11 can also enhance leptin signaling by activating MAPK1/3
through growth factor receptor-bound protein 2 (GRB2). Activation
of LEPR induces PTPN11 phosphorylation [48,53]. Phosphorylated
PTPN11 provides a binding site for GRB2 leading to the activation of
MAPK1/3 pathway through RAS-RAF-MEK signaling module [60]. |
| |
| IRS/PI-3K signaling module |
| |
| Leptin regulates IRS/PI-3K by promoting the interaction
and formation of SH2B/JAK2/IRS complex. In response to leptin
stimulation, SH2B adaptor protein 1 (SH2B1) recruits insulin receptor
substrates 1 and 2 (IRS1 and IRS2) to JAK2 and thus, inducing their
phosphorylation [61]. Phosphorylated IRS1/2 further interact with p85
subunit of phosphatidylinositol 3-kinase (PI-3K) [62]. The stimulation of PI3K leads to the activation of protein kinases such as protein kinase
B (AKT1) and downstream signaling cascades such as mammalian
target of rapamycin (MTOR) [63], nitric oxide synthase 3 (NOS3) [64],
phosphodiesterase 3A, cGMP-inhibited (PDE3A) [65] and results in
the regulation of glycogen synthase kinase 3 alpha/beta (GSK3A/B)
proteins [61]. In addition, activated AKT also activates IkappaB kinases
(IKKs), which induce the activation and nuclear translocation of NFkappaB
[63]. |
| |
| AMPK/ACC signaling module |
| |
| Leptin signaling activates 5’-AMP-activated protein kinase
(AMPK) module. AMPK is activated in response to a rise in AMP/ATP
ratio [66]. Activated AMPKs switch off the ATP-consuming process,
i.e., fatty acid biosynthesis by inactivating a key enzyme in the fatty
acid biosynthesis-acetyl-CoA carboxylase (ACC). Activated AMPKs
are also responsible for switching on the catabolic processes including
stimulation of fatty acid oxidation in the skeletal muscle, which
produces ATP [67,68]. Thus, AMPKs regulates various processes such
as glucose homeostasis, hepatic gluconeogenesis and lipid metabolism
[69]. |
| |
| PLC-gamma signaling module |
| |
| Stimulation of leptin receptor with leptin induces the activation of
Phospholipase C gamma (PLC-gamma) [70,71]. Activated PLC-gamma
hydrolyses phospholipid phosphatidylinositol-4,5-bisphosphate (PIP2)
to generate inositol 1,4,5-triphosphate (IP3) and diacylglycerol (DAG).
These products regulate intracellular calcium levels and protein kinase
C activation [72,70]. |
| |
| Graphical representation and Visualization of LEP/LEPR
signaling pathway |
| |
| We have curated 108 molecules involved in 62 PPIs, 97 catalytic
events, 10 activation and 11 translocation events. We recently
developed NetSlim [73], as an extension of NetPath, to retrieve a
rather confident set of reactions from the curated data. NetSlim criteria
included |
| |
| i) each reaction should be supported by two or more research
articles and |
| |
| ii) the reaction proved in high-throughput experiments
should have support from at least one low-throughput experiment. |
|
| |
| If a
particular reaction was not supported by two different research articles
the following criteria were applied: |
| |
| i) the reaction should be proved in
two different cell types; |
| |
| ii) in case of protein- protein interactions, the
interaction were considered if the two proteins existed as components
of a complex; and |
| |
| iii) if the reactions were reported in expert review
articles. |
| |
| We applied NetSlim criteria to leptin signaling pathway data and
selected 73 molecules involved in 89 reactions, which were made
available in NetSlim resource (http://www.netpath.org/netslim/
Leptin_pathway.html). These selected reactions were depicted as
leptin pathway map as shown in Figure 1. We generated this pathway
diagram using PathVisio [74], which is an improved visualization tool
incorporating features of GenMAPP [75]. |
| |
|
Figure 1: Comparison of the nucleotide sequences of the GS promoter regions in B. clausii, B. halodurans and B. subtilis. The proposed -35 and -10 promoter elements
are underlined. The TnrA sites are shown in boxes. The translational start site is indicated by bold italic letters. |
|
| |
| In the NetSlim version of leptin pathway map, each molecule
represented as node in the map is linked to its corresponding NetPath
molecule page and specific protein pages of other databases such
as HPRD [76,77]. The edge of each reaction is hyperlinked to its
respective PubMed identifiers (Map with citation). The reactions
that occur downstream of leptin receptor stimulation are represented
by solid or dashed edges. Direct reactions are represented by solid
edges and dashed edges symbolize induced or indirect. Protein protein interactions, enzyme-catalysis reactions, activation/inhibition
reactions and translocation events are represented in different colors
as indicated in the legend. The arrangement of molecules in the map
was derived from |
| |
| i) inhibitor based assays; |
| |
| ii) mutation based assays; |
| |
|
iii) knock out studies; |
| |
| iv) canonical pathways; and |
| |
| v) review articles. |
| |
| The NetSlim version of the leptin pathway map can be downloaded
from NetSlim database in various formats such as .gpml, .GenMAPP,
.png and .pdf. |
| |
| Data formats and availability |
| |
| NetPath is a resource of signaling pathways previously developed
by our group [78]. We submitted leptin pathway data curated in this
study into NetPath as an additional pathway. NetPath and NetSlim resources
are made freely accessible by scientific community. Overviews
of leptin pathway as seen in NetPath and NetSlim databases are provided
in Figure 2 and Figure 3 (included as supplementary data), respectively.
Complete set of curated reactions in leptin pathway can be
downloaded from NetPath at www.netpath.org/pathway/NetPath_22.
The reactions in NetSlim version of the leptin pathway can be downloaded
from NetSlim at http://www.netpath.org/netslim/Leptin_pathway.
html. |
| |
| The pathway data from NetPath and NetSlim is available
in various standard community data exchange formats such as Proteomics
Standards Initiative for Molecular Interaction (PSI-MI version
2.5), Biological PAthway eXchange (BioPAX level 3) and Systems Biology
Markup Language (SBML version 2.1) [79,80,81]. The availability
of data in these formats allows interoperability with various pathway
analysis software tools such as Cytoscape [82]. Gene regulation data is
made available in tab-delimited and Microsoft Excel formats. |
| |
| Conclusion |
| |
| Leptin signaling pathway map was developed based on data
retrieved from relevant published research articles on leptin signaling.
The data presented in this study summarizes the role of leptin in
the activation of multiple signaling modules implicated in various
physiological processes. In view of its biomedical importance, we
anticipate that the availability of a comprehensive pathway map will
further accelerate the research on leptin and its associated functions.
We also seek active participation of biomedical community for the
qualitative and quantitative enrichment of leptin pathway information. Biomedical experts can send their suggestions and critical comments
through http://www.netpath.org/comments. Leptin pathway map is
freely downloadable at www.netpath.org/pathway/NetPath_22 and
http://www.netpath.org/netslim/Leptin_pathway.html in various data
formats. |
| |
| Acknowledgements |
| |
| We thank the Department of Biotechnology, Government of India for research
support to the Institute of Bioinformatics, Bangalore. Pachakkil A. Haridas Nidhina
is a recipient of a Junior Research Fellowship from the Council of Scientific
and Industrial Research (CSIR), New Delhi, India. Rajesh Raju, Babylakshmi
Muthusamy and Jyoti Sharma are recipients of a Senior Research Fellowship from
the Council of Scientific and Industrial Research (CSIR), New Delhi, India. H.C.
Harsha is a Wellcome Trust/DBT India Alliance Early Career Fellow. T. S Keshava
Prasad is a recipient of a Young Investigator award from DBT. |
| |
|
| References |
| |
- Hoggard N, Hunter L, Duncan JS, Williams LM, Trayhurn P, et al.(1997) Leptin
and leptin receptor mRNA and protein expression in the murine fetus and
placenta. Proc Natl Acad Sci U S A 94:11073-11078.
- Sobhani I, Bado A, Vissuzaine C, Buyse M, Kermorgant S, et al.(2000) Leptin
secretion and leptin receptor in the human stomach. Gut 47:178-183.
- Devos R, Guisez Y, Van der Heyden J, White DW, Kalai M et al.(1997) Ligandindependent
dimerization of the extracellular domain of the leptin receptor and
determination of the stoichiometry of leptin binding. J Biol Chem 272:18304-
18310.
- Tartaglia LA, Dembski M, Weng X, Deng N, Culpepper J et al.(1995)
Identification and expression cloning of a leptin receptor, OB-R. Cell 83:1263-
1271.
- Lin J, Barb CR, Matteri RL, Kraeling RR, Chen X et al.(2000) Long form leptin
receptor mRNA expression in the brain, pituitary, and other tissues in the pig. Domest Anim Endocrinol 19:53-61.
- Mercer JG, Hoggard N, Williams LM, Lawrence CB, Hannah LT et al. (1996)
Localization of leptin receptor mRNA and the long form splice variant (Ob-Rb)
in mouse hypothalamus and adjacent brain regions by in situ hybridization. FEBS Lett 387:113-116.
- Chua SC Jr, Koutras IK, Han L, Liu SM, Kay J et al. (1997) Fine structure of
the murine leptin receptor gene: splice site suppression is required to form two
alternatively spliced transcripts. Genomics 45:264-270.
- Lee GH, Proenca R, Montez JM, Carroll KM, Darvishzadeh JG et al. (1996)
Abnormal splicing of the leptin receptor in diabetic mice. Nature 379:632-635.
- Chen H, Charlat O, Tartaglia LA, Woolf EA, Weng X et al. (1996) Evidence that
the diabetes gene encodes the leptin receptor: identification of a mutation in the
leptin receptor gene in db/db mice. Cell 84:491-495.
- Fong TM, Huang RR, Tota MR, Mao C, Smith T et al.(1998) Localization of
leptin binding domain in the leptin receptor. Mol Pharmacol 53:234-240.
- Huang L, Wang Z, Li C (2001) Modulation of circulating leptin levels by its
soluble receptor. J Biol Chem 276:6343-6349.
- Mistrik P, Moreau F , Allen JM (2004) BiaCore analysis of leptin-leptin receptor
interaction: evidence for 1:1 stoichiometry. Anal Biochem 327:271-277.
- Bacart J, Leloire A, Levoye A, Froguel P, Jockers R et al. (2010) Evidence
for leptin receptor isoforms heteromerization at the cell surface. FEBS Lett
584:2213-2217.
- Bahrenberg G, Behrmann I, Barthel A, Hekerman P, Heinrich PC et al. (2002)
Identification of the critical sequence elements in the cytoplasmic domain
of leptin receptor isoforms required for Janus kinase/signal transducer and
activator of transcription activation by receptor heterodimers. Mol Endocrinol
16:859-872.
- White DW , Tartaglia LA (1999) Evidence for ligand-independent homooligomerization
of leptin receptor (OB-R) isoforms: a proposed mechanism
permitting productive long-form signaling in the presence of excess short-form
expression. J Cell Biochem 73:278-288.
- Kloek C, Haq AK, Dunn SL, Lavery HJ, Banks AS et al. (2002) Regulation of
Jak kinases by intracellular leptin receptor sequences. J Biol Chem 277:41547-
41555.
- Morash B, Li A, Murphy PR, Wilkinson M, Ur E (1999) Leptin gene expression
in the brain and pituitary gland. Endocrinology 140:5995-5998.
- Maness LM, Banks WA, Kastin AJ (2000) Persistence of blood-to-brain
transport of leptin in obese leptin-deficient and leptin receptor-deficient mice. Brain Res 873:165-167.
- Banks WA, DiPalma CR, Farrell CL (1999) Impaired transport of leptin across
the blood-brain barrier in obesity. Peptides 20:1341-1345.
- Ahima RS, Prabakaran D, Mantzoros C, Qu D, Lowell B et al (1996) Role of
leptin in the neuroendocrine response to fasting. Nature 382:250-252.
- Hamann A, Matthaei S (1996) Regulation of energy balance by leptin. Exp Clin
Endocrinol Diabetes 104:293-300.
- Cirillo D, Rachiglio AM, la Montagna R, Giordano A ,Normanno N (2008) Leptin
signaling in breast cancer: an overview. J Cell Biochem 105:956-964.
- Lonnqvist F, Arner P, Nordfors L, Schalling M (1995) Overexpression of the
obese (ob) gene in adipose tissue of human obese subjects. Nat Med 1:950-
953.
- Kelesidis T, Kelesidis I, Chou S, Mantzoros CS (2010) Narrative review: the
role of leptin in human physiology: emerging clinical applications. Ann Intern
Med 152:93-100.
- Sahu A (2003) Leptin signaling in the hypothalamus: emphasis on energy
homeostasis and leptin resistance. Front Neuroendocrinol 24:225-253.
- Saad MF, Damani S, Gingerich RL, Riad-Gabriel MG, Khan A et al (1997)
Sexual dimorphism in plasma leptin concentration. J Clin Endocrinol Metab
82:579-584.
- Riad-Gabriel MG, Jinagouda SD, Sharma A, Boyadjian R, Saad MF (1998) Changes in plasma leptin during the menstrual cycle. Eur J Endocrinol
139:528-531.
- Highman TJ, Friedman JE, Huston LP, Wong WW, Catalano PM (1998) Longitudinal changes in maternal serum leptin concentrations, body
composition, and resting metabolic rate in pregnancy. Am J Obstet Gynecol
178:1010-1015.
- Mantzoros CS, Flier JS, Rogol AD (1997) A longitudinal assessment of
hormonal and physical alterations during normal puberty in boys. V. Rising
leptin levels may signal the onset of puberty. J Clin Endocrinol Metab 82:1066-
1070.
- Moschos S, Chan JL, Mantzoros CS (2002) Leptin and reproduction: a review. Fertil Steril 77:433-444.
- Chehab FF, Lim ME, Lu R (1996) Correction of the sterility defect in homozygous
obese female mice by treatment with the human recombinant leptin. Nat Genet
12:318-320.
- de Luca C, Kowalski TJ, Zhang Y, Elmquist JK, Lee C et al. (2005) Complete
rescue of obesity, diabetes, and infertility in db/db mice by neuron-specific
LEPR-B transgenes. J Clin Invest 115:3484-3493.
- Malik NM, Carter ND, Murray JF, Scaramuzzi RJ, Wilson CA et al. (2001) Leptin requirement for conception, implantation, and gestation in the mouse. Endocrinology 142:5198-5202.
- Elefteriou F, Ahn JD, Takeda S, Starbuck M, Yang X et al. (2005) Leptin
regulation of bone resorption by the sympathetic nervous system and CART. Nature 434:514-520.
- Steppan CM, Crawford DT, Chidsey-Frink KL, Ke H ,Swick AG (2000) Leptin is
a potent stimulator of bone growth in ob/ob mice. Regul Pept 92:73-78.
- Lam QL, Lu L (2007) Role of leptin in immunity. Cell Mol Immunol 4:1-13
- Matarese G, Di Giacomo A, Sanna V, Lord GM, Howard JK et al. (2001)
Requirement for leptin in the induction and progression of autoimmune
encephalomyelitis. J Immunol 166:5909-5916.
- Wislowska M, Rok M, Jaszczyk B, Stepien K, Cicha M (2007) Serum leptin in
rheumatoid arthritis. Rheumatol Int 27:947-954
- Giannini E, Botta F, Cataldi A, Tenconi GL, Ceppa P et al. (1999) Leptin levels
in nonalcoholic steatohepatitis and chronic hepatitis C. Hepatogastroenterology
46:2422-2425.
- Yalcindag FN, Kisa U, Batioglu F, Yalcindag A, Ozdemir O et al. (2007) Serum
leptin levels in patients with ocular and nonocular Behcet’s disease. Mediators
Inflamm 2007:31986.
- Anagnostoulis S, Karayiannakis AJ, Lambropoulou M, Efthimiadou A,
Polychronidis A et al. (2008) Human leptin induces angiogenesis in vivo. Cytokine 42:353-357.
- Bennett BD, Solar GP, Yuan JQ, Mathias J, Thomas GR et al. (1996) A role
for leptin and its cognate receptor in hematopoiesis. Curr Biol 6:1170-1180.
- Montoye T, Piessevaux J, Lavens D, Wauman J, Catteeuw D et al. (2006)
Analysis of leptin signalling in hematopoietic cells using an adapted MAPPIT
strategy. FEBS Lett 580:3301-3307.
- Ishikawa M, Kitayama J, Nagawa H (2006) Expression pattern of leptin
and leptin receptor (OB-R) in human gastric cancer. World J Gastroenterol
12:5517-5522.
- Kim JY, Park HK, Yoon JS, Kim SJ, Kim ES et al. (2010) Molecular mechanisms
of cellular proliferation in acute myelogenous leukemia by leptin. Oncol Rep
23:1369-1374.
- Kandasamy K, Keerthikumar S, Raju R, Keshava Prasad TS, Ramachandra YL
et al. (2009) PathBuilder--open source software for annotating and developing
pathway resources. Bioinformatics 25:2860-2862.
- Dunn SL, Bjornholm M, Bates SH, Chen Z, Seifert M et al. (2005) Feedback
inhibition of leptin receptor/Jak2 signaling via Tyr1138 of the leptin receptor and
suppressor of cytokine signaling 3. Mol Endocrinol 19:925-938.
- Carpenter LR, Farruggella TJ, Symes A, Karow ML, Yancopoulos GD et al.
(1998) Enhancing leptin response by preventing SH2-containing phosphatase
2 interaction with Ob receptor. Proc Natl Acad Sci U S A 95:6061-6066.
- Seo J, Lee KJ (2004) Post-translational modifications and their biological
functions: proteomic analysis and systematic approaches. J Biochem Mol Biol
37:35-44.
- Carbon S, Ireland A, Mungall CJ, Shu S, Marshall B et al. (2009) AmiGO: online
access to ontology and annotation data. Bioinformatics 25:288-289.
- Jiang L, Li Z, Rui L (2008) Leptin stimulates both JAK2-dependent and JAK2-
independent signaling pathways. J Biol Chem 283:28066-28073.
- Carvalheira JB, Siloto RM, Ignacchitti I, Brenelli SL, Carvalho CR et al. (2001)
Insulin modulates leptin-induced STAT3 activation in rat hypothalamus. FEBS
Lett 500:119-124.
- Li C, Friedman JM (1999) Leptin receptor activation of SH2 domain containing
protein tyrosine phosphatase 2 modulates Ob receptor signal transduction. Proc Natl Acad Sci U S A 96:9677-9682.
- Ren D, Li M, Duan C, Rui L (2005) Identification of SH2-B as a key regulator of
leptin sensitivity, energy balance, and body weight in mice. Cell Metab 2:95-
104.
- Baumann H, Morella KK, White DW, Dembski M, Bailon PS et al. (1996)
The full-length leptin receptor has signaling capabilities of interleukin 6-type
cytokine receptors. Proc Natl Acad Sci U S A 93:8374-8378.
- Cao Q, Mak KM, Ren C , Lieber CS (2004) Leptin stimulates tissue inhibitor
of metalloproteinase-1 in human hepatic stellate cells: respective roles of the
JAK/STAT and JAK-mediated H2O2-dependant MAPK pathways. J Biol Chem
279:4292-4304.
- Laubner K, Kieffer TJ, Lam NT, Niu X, Jakob F et al. (2005) Inhibition of
preproinsulin gene expression by leptin induction of suppressor of cytokine
signaling 3 in pancreatic beta-cells. Diabetes 54:3410-3417.
- Martens N, Uzan G, Wery M, Hooghe R, Hooghe-Peters EL et al. (2005) Suppressor of cytokine signaling 7 inhibits prolactin, growth hormone, and
leptin signaling by interacting with STAT5 or STAT3 and attenuating their
nuclear translocation. J Biol Chem 280:13817-13823.
- Lund IK, Hansen JA, Andersen HS, Moller NP, Billestrup N (2005) Mechanism
of protein tyrosine phosphatase 1B-mediated inhibition of leptin signalling. J
Mol Endocrinol 34:339-351.
- Pai R, Lin C, Tran T, Tarnawski A (2005) Leptin activates STAT and ERK2
pathways and induces gastric cancer cell proliferation. Biochem Biophys Res
Commun 331:984-992.
- Duan C, Li M, Rui L (2004) SH2-B promotes insulin receptor substrate 1 (IRS1)-
and IRS2-mediated activation of the phosphatidylinositol 3-kinase pathway in
response to leptin. J Biol Chem 279:43684-43691.
- Benomar Y, Roy AF, Aubourg A, Djiane J, Taouis M (2005) Cross downregulation
of leptin and insulin receptor expression and signalling in a human
neuronal cell line. Biochem J 388:929-939.
- Lam QL, Zheng BJ, Jin DY, Cao X, Lu L (2007) Leptin induces CD40 expression
through the activation of Akt in murine dendritic cells. J Biol Chem 282:27587-
27597.
- Goetze S, Bungenstock A, Czupalla C, Eilers F, Stawowy P et al. (2002)
Leptin induces endothelial cell migration through Akt, which is inhibited by
PPARgamma-ligands. Hypertension 40:748-754.
- Elbatarny HS, Maurice DH (2005) Leptin-mediated activation of human platelets:
involvement of a leptin receptor and phosphodiesterase 3A-containing cellular
signaling complex. Am J Physiol Endocrinol Metab 289:E695-702.
- Morris DL, Rui L (2009) Recent advances in understanding leptin signaling and
leptin resistance. Am J Physiol Endocrinol Metab 297:E1247-1259.
- Kahn BB, Alquier T, Carling D, Hardie DG (2005) AMP-activated protein kinase:
ancient energy gauge provides clues to modern understanding of metabolism. Cell Metab 1:15-25.
- Minokoshi Y, Kim YB, Peroni OD, Fryer LG,Muller C et al. (2002) Leptin
stimulates fatty-acid oxidation by activating AMP-activated protein kinase. Nature 415:339-343.
- Lim CT, Kola B, Korbonits M (2010) AMPK as a mediator of hormonal signalling. J Mol Endocrinol 44:87-97.
- Dellas C, Schafer K, Rohm IK, Lankeit M, Leifheit M et al. (2007) Leptin
signalling and leptin-mediated activation of human platelets: importance of
JAK2 and the phospholipases Cgamma2 and A2. Thromb Haemost 98:1063-
1071.
- Qiu J, Fang Y, Ronnekleiv OK, Kelly MJ (2010) Leptin excites
proopiomelanocortin neurons via activation of TRPC channels. J Neurosci
30:1560-1565.
- Carpenter G, Ji Q (1999) Phospholipase C-gamma as a signal-transducing
element. Exp Cell Res 253:15-24.
- Raju R, Nanjappa V, Balakrishnan L, Radhakrishnan A, Thomas JK, et al.
(2011) Netslim: High-confidence curated signaling maps. Database. In press.
- Van Iersel MP, Kelder T, Pico AR, Hanspers K, Coort S et al. (2008) Presenting
and exploring biological pathways with PathVisio. BMC Bioinformatics 9:399.
- Salomonis N, Hanspers K, Zambon AC, Vranizan K, Lawlor SC et al. (2007)
GenMAPP 2: new features and resources for pathway analysis. BMC
Bioinformatics 8:217.
- Keshava Prasad TS, Goel R, Kandasamy K, Keerthikumar S, Kumar S et al.
(2009) Human Protein Reference Database--2009 update. Nucleic Acids Res
37:D767-772.
- Peri S, Navarro JD, Amanchy R, Kristiansen TZ, Jonnalagadda CK et al. (2003)
Development of human protein reference database as an initial platform for
approaching systems biology in humans. Genome Res 13:2363-2371.
- Kandasamy K, Mohan SS, Raju R, Keerthikumar S, Kumar GS et al. (2010) NetPath: a public resource of curated signal transduction pathways. Genome
Biol 11:R3.
- Demir E, Cary MP, Paley S, Fukuda K, Lemer C et al. (2011) The BioPAX
community standard for pathway data sharing. Nat Biotechnol 28:935-942.
- Hermjakob H, Montecchi-Palazzi L, Bader G, Wojcik J, Salwinski L et al. (2004)
The HUPO PSI’s molecular interaction format--a community standard for the
representation of protein interaction data. Nat Biotechnol 22:177-183.
- Hucka M, Finney A, Sauro HM, Bolouri H, Doyle JC et al. (2003) The systems
biology markup language (SBML): a medium for representation and exchange
of biochemical network models. Bioinformatics 19:524-531.
- Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT et al. (2003) Cytoscape:
a software environment for integrated models of biomolecular interaction
networks. Genome Res 13:2498-2504.
|
| |
|
|
|
This Article |
DOWNLOAD |
|
CONTRIBUTE |
|
SHARE |
|
EXPLORE |
|
 |
 |
| |
|
| |
| |
| |
|
Untitled Document
|
|
|
|
|